Navigation Links
Media Spotlight Shines on Dr. Siegal's Cookie Diet While Major Study Reveals Doubling of U.S. Type II Diabetes Cases During Past Ten Years
Date:11/4/2008

d in more than two dozen major media outlets including NBC's Today Show, CBS' Early Show, The FOX Morning Show, the New York Times, and the Washington Post.

"I enjoyed appearing on Good Morning Arizona with Pete Molina and telling the story of his success," said Dr. Siegal, known affectionately by patients as the Cookie Doctor(TM). "My favorite media interviews are those that include one of my patients or a CookieDiet.com customer who has lost weight. Their success stories inspire others who may have lost hope that they, too, can achieve a healthy weight."

On Friday-the day after the Good Morning Arizona segment aired-many major news sources, including The Associated Press (full article: http://ap.google.com/article/ALeqM5ixhEAD2EhCpmtNPkTJFfCthte8GAD945MN5G1), reported on a study that indicates that in the United States the incidence of Type II diabetes of which obesity is considered a leading cause has doubled in the past ten years. Coincidentally, Mr. Molina, who has Type II adult onset diabetes, told the GMA host that, since starting his diet, his diabetes has been easier to control and that his personal physician has actually instructed him to discontinue his diabetes medication.

"Obesity is a leading cause of Type II diabetes. Although not every diabetic who loses weight is able to eliminate their medications as Pete Molina's doctor has reportedly advised, I've had thousands of diabetic patients over the years whose medications have been reduced or even eliminated once their excess weight came off," added Dr. Siegal.

The Forbes.com article (which will appear in the November 17th print edition of Forbes) focused on the retail side of the Dr. Siegal's COOKIE DIET(R) business which was launched in May 2007. Prior to that, Dr. Siegal's hunger-controlling cookies and other foods were only available to his own patients and those of other d
'/>"/>

SOURCE Dr. Siegal's Cookie Diet
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NIAID media availability: Seizures following parasitic infection associated with brain swelling
2. Survey Reveals Consumer Interest in New Media Formats for Health Information From Hospitals
3. American Media Inc. Names Chris Lockwood, Mike Carlson, and Allan Donnelly to Lead Editorial Teams at Enthusiast Group of Fitness Titles
4. Media Affects Public Perception of Infectious Diseases
5. AUDIO from Medialink and CIGNA: An Ailing Economy Changing How Many Take Care of Their Own Health
6. Less Exposure to Violent Media Makes Youths Less Aggressive
7. Media coverage affects how people perceive threat of disease: study
8. Media coverage of lung cancer is increasing, and increasingly negative, new report shows
9. AUDIO from Medialink and Philips Norelco: Vote to Change the Face of Mens Health this November
10. Webcast Alert: Medial Saude S/A Announces Third Quarter 2008 Earnings Conference Call Webcast
11. Global Scientific Research Collaboration Leads to Breakthrough in Culturing HEK 293 Cells in Animal-free Media
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 1Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 2FRCs Tony Perkins Commends Pro life Lawmakers Who Oppose Federal Funding of Abortion 51676 1FRCs Tony Perkins Commends Pro life Lawmakers Who Oppose Federal Funding of Abortion 51676 2Sono Tek Announces First Quarter Results 51672 1Sono Tek Announces First Quarter Results 51672 2Sono Tek Announces First Quarter Results 51672 3